AMN Slides on Purchase by symplr
symplr®, a leading provider of enterprise healthcare operations software backed by Clearlake Capital Group, L.P. and Charlesbank Capital Partners LLC, has acquired the Smart Square® scheduling software from AMN Healthcare (NYSE: AMN)."A critical way for hospitals and health systems to unlock greater value from their technology is to arm them with intelligent, purpose-built solutions," said BJ Schaknowski, CEO of symplr. "Bringing Smart Square's AI-driven scheduling engine into the symplr Operations Platform helps us stay ahead of the emerging and dynamic needs of the healthcare workforce."symplr's Time and Attendance technology has earned the Best in KLAS category for timekeeping for over two decades, largely due to its ability to manage the healthcare industry's most complex pay policies. Smart Square was also awarded 2025 Best in KLAS for Scheduling: Nurse & Staff. “The solution is a leader in leveraging AI predictive analytics and real-time EMR-driven staffing, highly tailored for complex healthcare environments. With this strategic acquisition, symplr reaffirms its commitment to empowering healthcare organizations with actionable data and technology to create efficiencies, contain costs, and improve patient outcomes."Advancing our software offerings to further reduce administrative burden and streamline processes is imperative," said Theresa Meadows, Chief Information Officer in Residence of symplr. "This acquisition deepens our investment in automation and AI, helping healthcare leaders anticipate staffing needs, deploy resources more intelligently to the front lines of healthcare operations, and enhance the user experience."AMN shares lost 39 cents, or 1.8%, to $21.62.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


